ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,135Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 487

$382K Total Retail Price of All Prescriptions

Rank: 89 out of 487

246 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 246 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 246 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 4,920 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 280 238 1 1
FUROSEMIDE 210 170 2 7
LISINOPRIL 181 140 3 5
SIMVASTATIN 166 111 4 4
METFORMIN HCL 143 116 5 8
OMEPRAZOLE 139 101 6 2
CYMBALTA 138 92 7 34
SERTRALINE HCL 129 118 8 21
ATORVASTATIN CALCIUM 124 106 9 18
POTASSIUM CHLORIDE 121 118 10 10
HYDROCODONE-ACETAMINOPHEN 101 59 S3 11 3
ALENDRONATE SODIUM 94 87 12 27
AMLODIPINE BESYLATE 91 69 13 6
MELOXICAM 87 79 14 26
METOPROLOL TARTRATE 82 74 15 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 64 16 24
LOVASTATIN 76 75 17 30
TAMSULOSIN HCL 74 67 18 25
LANTUS 68 54 19 44
WARFARIN SODIUM 67 59 20 11
CITALOPRAM HBR 67 61 20 12
BUPROPION XL 66 39 22 97
GABAPENTIN 65 61 23 13
ENABLEX 65 65 23 225
NEXIUM 64 49 25 41
SINGULAIR 61 43 26 125
GLIMEPIRIDE 59 45 27 35
CYCLOBENZAPRINE HCL 53 23 R 28 64
DIOVAN HCT 53 53 28 120
COMBIVENT 50 36 30 116
TRAMADOL HCL-ACETAMINOPHEN 50 43 30 262
HYDROCHLOROTHIAZIDE 50 26 30 9
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.